News
- Author:
- Sara Freeman
Publish date: May 15, 2018
LIVERPOOL, ENGLAND – Growth factors under development for OA aim to treat the growing population of patients with OA at a younger age.
News
- Author:
- Sara Freeman
Publish date: May 14, 2018
LIVERPOOL, ENGLAND – There is no evidence that pulmonary fibrosis is a complication of long-term methotrexate use and treatment should continu...
News
- Author:
- Sara Freeman
Publish date: May 14, 2018
LIVERPOOL, ENGLAND – The novel intra-articular therapy improved multiple outcomes including knee pain, with a trend towards reversing structural da...
News
- Author:
- Sara Freeman
Publish date: May 3, 2018
LIVERPOOL, ENGLAND - Heart disease accounts for most granulomatosis with polyangiitis deaths 1-5 years after diagnosis.
News
- Author:
- Sara Freeman
Publish date: May 2, 2018
LIVERPOOL, ENGLAND – Remission brings better quality of life compared with low disease activity.
News
- Author:
- Sara Freeman
Publish date: April 30, 2018
LIVERPOOL, ENGLAND – Lateral wedge insoles were an effective means of reducing painful medial knee osteoarthritis in prescreened patients.
News
- Author:
- Sara Freeman
Publish date: April 30, 2018
LIVERPOOL, ENGLAND – The 6-month trial showed no reduction in pain versus placebo on an 11-point numerical rating scale.
News
- Author:
- Sara Freeman
Publish date: April 29, 2018
Knee pain, reduced quality of life, and osteoarthritis occur more than 30 years after ACL rupture.
News
- Author:
- Sara Freeman
Publish date: April 27, 2018
LIVERPOOL, ENGLAND – OA was associated with a 15% increased risk of mortality in the general population.
News
- Author:
- Sara Freeman
Publish date: March 22, 2018
But the absolute difference in the rate of confirmed disability progression versus placebo was small.
News
- Author:
- Sara Freeman
Publish date: March 21, 2018
Expanded patient population eligible for whole breast hypofractionated radiation therapy in updated ASTRO guideline.
News
- Author:
- Sara Freeman
Publish date: November 29, 2017
The study examines several rounds of cotesting with the high-risk HPV test and cytology.
News
- Author:
- Sara Freeman
Publish date: November 4, 2017
In the real world, an SGLT2 inhibitor may protect against heart disease better that a DPP-4 inhibitor.
News
- Author:
- Sara Freeman
Publish date: October 19, 2017
LISBON – Handle with care: sotagliflozin imposes risk of DKA while dropping HbA1c.
News
- Author:
- Sara Freeman
Publish date: October 18, 2017
LISBON – Sodium-glucose cotransporter inhibitors appear to be back on track for adjunctive use in people with T1DM.
